US Lawmakers Declare "Moral Fight" in Tech War with China Over AI, Chips

Senior US lawmakers have framed the technological competition with China across AI, semiconductors, and biotech as a critical "moral fight" for global power. They advocate for a multi-pronged strategy combining stricter export controls on advanced chips, prioritizing domestic customers, and building resilient supply chains. The discussions highlight a significant policy shift in Washington, viewing these technologies as interconnected national security battlegrounds. Key vulnerabilities include U.S. dependence on China in critical supply chains, which officials argue must be urgently addressed.

Key Points: US-China Tech War: AI, Chips & Biotech Become New Fronts

  • Stricter export controls on advanced chips
  • Shift from free trade to a "defense mentality"
  • Reducing supply chain dependence on China
  • Biotechnology as a new national security front
3 min read

US sharpens tech war with China across AI, chips, biotech

Top US lawmakers frame competition with China in AI, semiconductors, and biotech as a "moral fight," pushing for export controls and supply chain resilience.

"This isn't just a technological race... This is a moral fight. - Senator Jim Banks"

Washington, March 25

As the Trump Administration expands its strategic competition with China across artificial intelligence, semiconductors, and biotechnology, top American lawmakers warned that the contest is not just technological but a "moral fight" that will shape global power and economic security.

At the Hill & Valley Forum in Washington, senior lawmakers outlined a multi-front strategy to counter China's rise in critical technologies, combining export controls, domestic investment, and closer coordination with allies.

Senator Jim Banks framed the artificial intelligence race in stark geopolitical terms and said that the second Cold War is related to the AI race, adding, "We can't let China win it. That's the bottom line."

He pointed to the Trump administration's AI action plan, which calls for stricter export controls on advanced semiconductor chips to China and other adversaries. Banks said his proposed GAIN AI Act - already passed in the Senate as part of the National Defense Authorization Act - is central to tightening those restrictions.

"... we need to make sure that we're not helping our biggest enemy... that's the big picture on Capitol Hill," he said.

Banks argued the stakes go beyond innovation or market leadership.

"This isn't just a technological race... This is a moral fight. And we know that the PRC is going to lie, steal, and cheat," he said.

He stressed that export controls must prevent adversaries from accessing cutting-edge American chips, while domestic demand should take priority.

"... when there is a domestic customer base in the United States of America, they should get priority for American-made chips over our biggest enemy," Banks said.

Representative John Moolenaar, Chairman of the House Select Committee on China, echoed the need for a tougher posture, even as he acknowledged the tension with traditional US economic principles.

"I still think the best case is when you have the freedom to innovate... more free trade with free countries," Moolenaar said.

But competition with China, he added, requires a shift.

"It requires almost like a defence mentality, where you're saying, 'Okay, let's use every tool possible to make sure we win this competition,'" he said.

Moolenaar highlighted a critical vulnerability - US dependence on China in key supply chains adding, " we're actually dependent on our chief rival, and we have to stop enabling them to continue to defeat us on this," he said.

He warned that adversaries could leverage American technology to accelerate their own capabilities, underscoring the need for stronger controls, supply chain resilience and workforce development.

The competition is also expanding into biotechnology, another sector increasingly viewed through a national security lens.

Senator Todd Young, Chairman of the National Security Commission on Emerging Biotechnology, highlighted the importance of US leadership in the field and pointed to a comprehensive action plan submitted to Congress.

Young, speaking alongside ARPA-H Director Alicia Jackson and Curie.Bio Co-Founder Zach Weinberg, underscored the role of public-private collaboration in maintaining an edge in emerging technologies.

The discussions at the forum reflected a broader shift in Washington, where artificial intelligence, semiconductors and biotechnology are now seen as interconnected battlegrounds in strategic competition with China.

- IANS

Share this article:

Reader Comments

P
Priya S
Calling it a "moral fight" feels like a stretch. It's about economic dominance and control. India should stay pragmatic, learn from both, and build partnerships that serve our national interest, not get drawn into ideological battles.
V
Vikram M
The US is finally realizing supply chain risks? We in India have been talking about this for years. Their dependence on China is their own making. Hope this pushes more companies to 'China+1' and India benefits with new manufacturing.
S
Sarah B
As someone working in tech, the focus on biotech is interesting. It's the next frontier. Indian startups in bio-AI and genomics have huge potential if they get the right policy support and don't face over-regulation.
R
Rohit P
Good move by US. China's tactics in tech have been questionable for long. But India must be careful. We need American tech and investment, but also can't afford to completely alienate China. Walking the diplomatic tightrope is key. 🤞
K
Kavya N
The "second Cold War" framing is dangerous. It creates a binary world. India's position should be of a leading tech power in its own right, not a side in someone else's war. Our IITs and tech parks are full of brilliant minds ready to innovate.

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50